Medications for Metabolic Bone Diseases

6 results

  • Calcitriol (calcitriol 0.25 mcg)

    (Calcitriol 0.25 mcg)
    ATLANTIC BIOLOGICALS CORP.
    Usage: Calcitriol is indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, hypocalcemia in dialysis patients, and hypocalcemia due to postsurgical or idiopathic hypoparathyroidism. It enhances calcium absorption and may reduce parathyroid hormone levels and bone disease manifestations.

  • Calcitriol (calcitriol capsules 0.25 mcg)

    (Calcitriol Capsules 0.25 mcg)
    Aphena Pharma Solutions - Tennessee, LLC
    Usage: Calcitriol capsules are indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, hypocalcemia in dialysis patients, and hypocalcemia in individuals with hypoparathyroidism, including postsurgical and idiopathic cases. It promotes calcium absorption and reduces associated metabolic bone disease effects.

  • Calcitriol (calcitriol)

    (Calcitriol)
    Aphena Pharma Solutions - Tennessee, LLC
    Usage: Calcitriol capsules are indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, addressing hypocalcemia and metabolic bone disease in dialysis patients, and treating hypocalcemia in individuals with postsurgical, idiopathic, or pseudohypoparathyroidism.

  • Calcitriol (calcitriol)

    (Calcitriol)
    ATLANTIC BIOLOGICALS CORP.
    Usage: Calcitriol is indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, hypocalcemia in dialysis patients, and hypocalcemia in individuals with postsurgical, idiopathic, or pseudohypoparathyroidism. It helps improve calcium absorption and may reduce parathyroid hormone levels and related bone complications.

  • Fosteum plus (dicalcium malate, pentacalcium hydroxide triphosphate, phosphate, genistein aglycone, citrated zinc bisglycinate, trans-menaquinone-7, cholecalciferol)

    (dicalcium malate, pentacalcium hydroxide triphosphate, phosphate, genistein aglycone, citrated zinc bisglycinate, trans-menaquinone-7, cholecalciferol)
    Primus Pharmaceuticals, Inc.
    Usage: Fosteum PLUS is indicated for the dietary management of osteopenia and osteoporosis. It may be combined with additional calcium and vitamin D3, as prescribed by a physician, and can be taken with or without food.

  • Pamidronate disodium (pamidronate disodium)

    (PAMIDRONATE DISODIUM)
    Hospira, Inc.
    Usage: Pamidronate disodium is indicated for treating moderate to severe hypercalcemia of malignancy, Paget's disease, and osteolytic bone metastases from breast cancer and multiple myeloma. It is used alongside hydration and standard antineoplastic therapies, demonstrating significant biochemical and clinical benefits in affected patients.